Literature DB >> 32953307

Paying in Blood: A Case of Thrombocytopenia in Covid-19.

Jahanzeb Malik1, Muhammad Javaid1, Omaid Majedi1, Uzma Ishaq2, Tayyaba Zahid1.   

Abstract

Novel coronavirus disease 2019 (COVID-19) primarily involves the respiratory system. Consumptive coagulopathy is seen in acute respiratory distress syndrome (ARDS) and multi-organ failure (MOF). Usually, only severely sick patients develop mild thrombocytopenia. We present a case of mildly symptomatic young adult, presenting with severe thrombocytopenia. She responded well to corticosteroids.
Copyright © 2020, Malik et al.

Entities:  

Keywords:  covid 19; covid associated thrombocytopenia; thrombocytopenia

Year:  2020        PMID： 32953307      PMCID： PMC7491688          DOI： 10.7759/cureus.9791

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  11 in total

Review 1.  Coagulopathy in COVID-19: Focus on vascular thrombotic events.

Authors:  Wei Shi; Jiagao Lv; Li Lin
Journal:  J Mol Cell Cardiol       Date:  2020-07-15       Impact factor: 5.000

2.  Coagulation abnormalities and thrombosis in patients with COVID-19.

Authors:  Marcel Levi; Jecko Thachil; Toshiaki Iba; Jerrold H Levy
Journal:  Lancet Haematol       Date:  2020-05-11       Impact factor: 18.959

3.  Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered questions.

Authors:  Ariunzaya Amgalan; Maha Othman
Journal:  J Thromb Haemost       Date:  2020-05-06       Impact factor: 5.824

4.  Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China.

Authors:  Hongdou Li; Shuang Wang; Fan Zhong; Wuyin Bao; Yipeng Li; Lei Liu; Hongyan Wang; Yungang He
Journal:  Front Med (Lausanne)       Date:  2020-04-30

5.  Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality.

Authors:  Mark R Geier; David A Geier
Journal:  Med Hypotheses       Date:  2020-04-22       Impact factor: 1.538

6.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Authors:  Ning Tang; Dengju Li; Xiong Wang; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-03-13       Impact factor: 5.824

7.  Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19.

Authors:  Julien Maquet; Margaux Lafaurie; Agnès Sommet; Guillaume Moulis
Journal:  Br J Haematol       Date:  2020-08-31       Impact factor: 8.615

8.  Isolated severe thrombocytopenia in a patient with COVID-19: A case report.

Authors:  Sara Sadr; SeyedAhmad SeyedAlinaghi; Fereshteh Ghiasvand; Malihe Hassan Nezhad; Nina Javadian; Roghieh Hossienzade; Fatemeh Jafari
Journal:  IDCases       Date:  2020-05-29

Review 9.  Mechanism of thrombocytopenia in COVID-19 patients.

Authors:  Panyang Xu; Qi Zhou; Jiancheng Xu
Journal:  Ann Hematol       Date:  2020-04-15       Impact factor: 3.673

10.  Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.

Authors:  Giuseppe Lippi; Mario Plebani; Brandon Michael Henry
Journal:  Clin Chim Acta       Date:  2020-03-13       Impact factor: 3.786
View more
  7 in total

1.  Post-acute COVID-19 syndrome and its prolonged effects: An updated systematic review.

Authors:  Talal Almas; Jahanzeb Malik; Abdulla K Alsubai; Syed Muhammad Jawad Zaidi; Raafe Iqbal; Kashif Khan; Muhammad Ali; Uzma Ishaq; Majid Alsufyani; Sebastian Hadeed; Reema Alsufyani; Reema Ahmed; Tushar Thakur; Helen Huang; Meetty Antony; Ishan Antony; Anhad Bhullar; Farida Kotait; Lubabah Al-Ani
Journal:  Ann Med Surg (Lond)       Date:  2022-06-15

2.  Effect of COVID-19 on lipid profile parameters and its correlation with acute phase reactants: A single-center retrospective analysis.

Authors:  Talal Almas; Jahanzeb Malik; Abdulla K Alsubai; Maryam Ehtesham; Talha Laique; Uzma Ishaq; Asad Mehmood; Syed Muhammad Jawad Zaidi; Sebastian Hadeed; Helen Huang; Mert Oruk
Journal:  Ann Med Surg (Lond)       Date:  2022-05-26

3.  The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.

Authors:  Lucia Novelli; Francesca Motta; Maria De Santis; Aftab A Ansari; M Eric Gershwin; Carlo Selmi
Journal:  J Autoimmun       Date:  2020-12-14       Impact factor: 7.094

4.  Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review.

Authors:  Kuo-Tung Tang; Bo-Chueh Hsu; Der-Yuan Chen
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

5.  Association of ABO blood group with COVID-19 severity, acute phase reactants and mortality.

Authors:  Uzma Ishaq; Asmara Malik; Jahanzeb Malik; Asad Mehmood; Azhar Qureshi; Talha Laique; Syed Muhammad Jawad Zaidi; Muhammad Javaid; Abdul Sattar Rana
Journal:  PLoS One       Date:  2021-12-14       Impact factor: 3.240

6.  Immune Thrombocytopenic Purpura (ITP) Following Natural COVID-19 Infection.

Authors:  Sisira Santhosh; Bilal Malik; Atefeh Kalantary; Arvind Kunadi
Journal:  Cureus       Date:  2022-07-05

7.  Severe Thrombocytopenia in COVID-19: A Conundrum in Dengue-endemic Areas.

Authors:  M B Adarsh; Anitha Abraham; P Kavitha; Meera M Nandakumar; Raman S Vaman
Journal:  Indian J Crit Care Med       Date:  2021-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.